Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer
HDRBTADTandrogen deprivation therapynivolumabnivolumab-relatedGG5 PCaprostate cancer (PCa)
…every 2 weeks) beginning 4 weeks prior to HDRBT, alongside ADT, HDRBT, and external beam radiation. The primary endpoint was to evalu…